PCRM Will Hold Webinar Series on “Tomorrow’s Data Today: Sunsetting the 2-year Carcinogenicity Assay”
The Physicians Committee for Responsible Medicine (PCRM) New Approach Methodologies (NAM) Use for Regulatory Applications (NURA) program is offering a free three-session training series on replacing the traditional two-year bioassay with a more effective, human-relevant carcinogenicity assessment. In “Tomorrow’s Data Today: Sunsetting the 2-year Carcinogenicity Assay,” toxicologists, risk assessors, and scientists will hear directly from other experts on the current progress among working groups, adverse outcome pathways (AOP) and integrated approaches to testing and assessment (IATA), case studies, and promising technologies to use in their weight of evidence carcinogenicity assessments. The webinars will be held:
Session 1: February 23, 2023
-
Timothy McGovern, Ph.D., Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA);
-
Joseph Manuppello, PCRM;
-
Mirjam Luijten, Ph.D., Dutch National Institute for Public Health and the Environment (RIVM), European Partnership for Alternative Approaches to Animal Testing (EPAA) Workgroup; and
-
Connie Mitchell, Health and Environmental Sciences Institute (HESI) Workgroup.
Session 2: March 2, 2023
-
Gina Hilton, Ph.D., PETA Science Consortium International e.V. (PSCI);
-
Susanne Stalford, Ph.D., Lhasa Ltd;
-
Miriam Jacobs, Ph.D., United Kingdom Health Security Agency (UKHSA); and
-
Sarah Dobreniecki, Ph.D., Office of Pesticide Programs (OPP), U.S. Environmental Protection Agency (EPA).
Session 3: March 9, 2023
-
Chris Corton, Ph.D., Office of Research and Development (ORD), EPA;
-
Ting Li, Ph.D., National Center for Toxicological Research (NCTR), FDA; and
-
Carole Yauk, Ph.D., University of Ottawa.
